Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression

Clavien, 2007, Strategies for safer liver surgery and partial liver transplantation, N Engl J Med, 356, 1545, 10.1056/NEJMra065156

Trevisani, 1996, The use of donor fatty liver for liver transplantation: a challenge or a quagmire?, J Hepatol, 24, 114, 10.1016/S0168-8278(96)80195-4

Halon, 2006, Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?, Transplant Proc, 38, 193, 10.1016/j.transproceed.2005.11.088

Wicklow, 2012, Metabolic consequences of hepatic steatosis in overweight and obese adolescents, Diabetes Care, 35, 905, 10.2337/dc11-1754

Todo, 1989, Primary nonfunction of hepatic allografts with preexisting fatty infiltration, Transplantation, 47, 903, 10.1097/00007890-198905000-00034

Selzner, 2001, Fatty liver in liver transplantation and surgery, Semin Liver Dis, 21, 105, 10.1055/s-2001-12933

Ploeg, 1993, Risk factors for primary dysfunction after liver transplantation—a multivariate analysis, Transplantation, 55, 807, 10.1097/00007890-199304000-00024

Pevni, 2008, New evidence for the role of TNF-alpha in liver ischaemic/reperfusion injury, Eur J Clin Invest, 38, 649, 10.1111/j.1365-2362.2008.01996.x

Hato, 2001, Attenuation of liver and lung injury after hepatic ischemia and reperfusion by a cytokine-suppressive agent, FR167653, Eur Surg Res, 33, 202, 10.1159/000049707

Jaeschke, 2006, Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions, Am J Physiol Gastrointest Liver Physiol, 290, G1083, 10.1152/ajpgi.00568.2005

Muller-Quernheim, 2011, MMPs are regulatory enzymes in pathways of inflammatory disorders, tissue injury, malignancies and remodelling of the lung, Eur Respir J, 38, 12, 10.1183/09031936.00079311

Soccal, 2000, Matrix metalloproteinases correlate with alveolar–capillary permeability alteration in lung ischemia–reperfusion injury, Transplantation, 70, 998, 10.1097/00007890-200010150-00002

Cheung, 2000, Matrix metalloproteinase-2 contributes to ischemia–reperfusion injury in the heart, Circulation, 101, 1833, 10.1161/01.CIR.101.15.1833

Romanic, 1998, Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size, Stroke, 29, 1020, 10.1161/01.STR.29.5.1020

Sarma, 2012, Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway, PLoS One, 7, e50826, 10.1371/journal.pone.0050826

Johansen, 2000, Serum YKL-40 is increased in patients with hepatic fibrosis, J Hepatol, 32, 911, 10.1016/S0168-8278(00)80095-1

Hottinger, 2011, YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma, Ann Neurol, 70, 163, 10.1002/ana.22360

Chen, 2011, Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives, Curr Cancer Drug Targets, 11, 239, 10.2174/156800911794519752

Ramachandran, 2012, Ischemia–reperfusion injury in rat steatotic liver is dependent on NFkappaB P65 activation, Transpl Immunol, 26, 201, 10.1016/j.trim.2012.01.001

Argiles, 1989, The obese Zucker rat: a choice for fat metabolism 1968–1988: twenty years of research on the insights of the Zucker mutation, Prog Lipid Res, 28, 53, 10.1016/0163-7827(89)90007-6

Kamada, 1983, A surgical experience with five hundred thirty liver transplants in the rat, Surgery, 93, 64

Woessner, 1995, Quantification of matrix metalloproteinases in tissue samples, Methods Enzymol, 248, 510, 10.1016/0076-6879(95)48033-1

Campbell, 2005, Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection, Am J Transplant, 5, 517, 10.1111/j.1600-6143.2005.00744.x

Tiriveedhi, 2012, A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection, Clin Exp Immunol, 167, 158, 10.1111/j.1365-2249.2011.04486.x

Vandooren, 2013, Zymography methods for visualizing hydrolytic enzymes, Nat Methods, 10, 211, 10.1038/nmeth.2371

Tiriveedhi, 2010, Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation, Biochem Biophys Res Commun, 399, 251, 10.1016/j.bbrc.2010.07.063

Tiriveedhi, 2012, HIF-1alpha signaling by airway epithelial cell K-alpha1-tubulin: role in fibrosis and chronic rejection of human lung allografts, Cell Immunol, 273, 59, 10.1016/j.cellimm.2011.11.006

Hamada, 2008, Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury, Hepatology, 47, 186, 10.1002/hep.21922

Page-McCaw, 2007, Matrix metalloproteinases and the regulation of tissue remodelling, Nat Rev Mol Cell Biol, 8, 221, 10.1038/nrm2125

Nagase, 2006, Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc Res, 69, 562, 10.1016/j.cardiores.2005.12.002

Pizano-Martinez, 2011, YKL-40 expression in CD14(+) liver cells in acute and chronic injury, World J Gastroenterol, 17, 3830, 10.3748/wjg.v17.i33.3830

Hu, 2007, Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases, Nat Rev Drug Discov, 6, 480, 10.1038/nrd2308

Shirahane, 2006, Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817, Surgery, 139, 653, 10.1016/j.surg.2005.10.002

Bradham, 1999, Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells, Liver Transpl Surg, 5, 282, 10.1002/lt.500050401

Yoshidome, 1999, Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB, Hepatology, 30, 203, 10.1002/hep.510300120

Racanelli, 2006, The liver as an immunological organ, Hepatology, 43, S54, 10.1002/hep.21060

Bode, 2005, Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?, Alcohol Clin Exp Res, 29, 166S, 10.1097/01.alc.0000189280.19073.28

Demetris, 2006, Liver biopsy interpretation for causes of late liver allograft dysfunction, Hepatology, 44, 489, 10.1002/hep.21280

Bigg, 2006, The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation, J Biol Chem, 281, 21082, 10.1074/jbc.M601153200

Mutlu, 2012, Proteasomal inhibition after injury prevents fibrosis by modulating TGF-beta(1) signalling, Thorax, 67, 139, 10.1136/thoraxjnl-2011-200717